Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shell to exit three offshore projects in Colombia

(Sharecast News) - Shell is to exit three of its co-owned offshore gas projects in Colombia after just four years as they no longer meet the company's "strategic ambitions". Shell, the operator in the projects, has held an equal share in the Col 5, Purple Angel and Fuerte Sur deepwater projects along with state-run Ecopetrol since December 2020.

Ecopetrol said that Shell's decision to pull out was due to "reasons related to its strategy and management of its global portfolio", and the two companies are working together to guarantee the continuity of the projects.

"These projects, which are technically and economically viable, are priorities for Ecopetrol and the country, and we are evaluating what actions should be implemented to maintain their continuity over time and develop the resources to ensure supply in the medium term," a statement from Ecopetrol said.

Meanwhile, a Shell spokesperson cited by Reuters said the blocs "no longer fit our strategic ambitions".

They continued: "Shell will continue to work to provide flexible energy products and solutions for Colombia such as the supply of LNG, as well as the high quality of lubricant products and fuels."

Shell's share price was up 0.4% at 2,443p by 1035 GMT.

Share this article

Related Sharecast Articles

RBC Capital ups price target on Hikma
(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.
Home Depot won't hike prices in response to tariffs, Q1 sales fall
(Sharecast News) - US do-it-yourself chain Home Depot on Tuesday held full-year sales forecasts and said it did not expect to raise prices in response to President Donald trump's tariffs.
Poolbeg raises nearly £5m to progress clinical trials
(Sharecast News) - Shares in biopharmaceutical group Poolbeg Pharma sank on Tuesday after the company revealed wider losses for the 2024 financial year as it raised nearly £5m in an oversubscribed placing as it progresses two key clinical trials.
Berenberg starts coverage of Accesso Technology at 'buy'
(Sharecast News) - Berenberg initiated coverage of Accesso Technology on Tuesday with a 'buy' rating and 775p price target.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.